Aleco.Pa
ALECO.PA operates in the Food & Drug Retailing industry, primarily generating revenue through the retail and distribution of food and drug products.
Business. ALECO.PA operates in the Food & Drug Retailing industry, primarily generating revenue through the retail and distribution of food and drug products.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ALECO.PA operates in the Food & Drug Retailing industry, primarily generating revenue through the retail and distribution of food and drug products.
ALECO.PA has a total equity of 3.3 million EUR and no debt, resulting in a debt-to-equity ratio of 0.0. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
The company's profitability and returns are not quantifiable due to the lack of detailed financial metrics such as return on invested capital (ROIC) or operating margins. However, the absence of debt suggests a conservative capital structure, which may support financial stability.
Segment and geographic exposure data are not available in the provided information, making it difficult to assess revenue concentration or geographic diversification.
Growth trajectory data is limited, but the company's revenue of 38.22 million EUR provides a baseline for future performance comparisons.
The company's risk assessment indicates a low dilution potential, with no significant dilution sources identified in the available documents. However, the lack of liquidity data introduces uncertainty regarding the company's ability to meet short-term obligations.
Recent events and filings are not detailed in the provided data, so no specific recent developments can be cited.
- ALECO.PA has a debt-free capital structure, which may reduce financial risk.
- The company's liquidity risk could not be assessed due to missing balance-sheet data.
- No detailed profitability metrics are available, limiting the ability to evaluate returns.
- Analysts have issued a strong buy recommendation with a mean price target of 3.00 EUR.
- The company's growth trajectory and segment performance are not quantified in the available data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,50 |
| Revenue | —no estimate | —no estimate | 45,9M EUR |
| Operating income | —no estimate | —no estimate | -2,4M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- ALECO.PA Market data — financials · 2026-05-27
- Ecomiam SA Market data — analyst estimates · 2026-05-27